| # | Country | Total Patents | |
|---|---|---|---|
| #1 | Canada | 4 | |
| #2 | Australia | 3 | |
| #3 | WIPO (World Intellectual Property Organization) | 3 | |
| #4 | EPO (European Patent Office) | 2 | |
| #5 | China | 1 | |
| #6 | Singapore | 1 |
| # | Industry | |
|---|---|---|
| #1 | Pharmaceuticals | |
| #2 | Biotechnology | |
| #3 | Measurement | |
| #4 | Organic fine chemistry |
| # | Technology | |
|---|---|---|
| #1 | Medical preparations | |
| #2 | Therapeutic chemical compounds | |
| #3 | Peptides | |
| #4 | Microorganisms | |
| #5 | Analysing materials | |
| #6 | Heterocyclic compounds |
| # | Name | Total Patents |
|---|---|---|
| #1 | Fang Jianmin | 14 |
| #2 | Yao Xuejing | 8 |
| #3 | Jiang Jing | 6 |
| #4 | Huang Changjiang | 4 |
| #5 | Bao Qianjing | 4 |
| #6 | Xu Qiaoyu | 4 |
| #7 | Li Zhuanglin | 4 |
| #8 | Luan Xuejing | 4 |
| #9 | Wang Ling | 4 |
| #10 | Liang Wang | 2 |
| Publication | Filing date | Title |
|---|---|---|
| WO2021037007A1 | Anti pd-l1 antibody and use thereof | |
| CA3094194A1 | Pharmaceutical formulations of her2 antibody-drug conjugate | |
| CN111670201A | Her2 concomitant diagnosis immunohistochemical detection antibody and application thereof | |
| CA3106493A1 | A linker for antibody-drug conjugates and its use | |
| SG11202101354RA | Bifunctional angiogenesis inhibitor and use thereof |